
Brian J. Gangle
Examiner (ID: 511, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1233 |
| Issued Applications | 798 |
| Pending Applications | 132 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18341280
[patent_doc_number] => 11638749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Tuberculosis antigen cassettes
[patent_app_type] => utility
[patent_app_number] => 16/756206
[patent_app_country] => US
[patent_app_date] => 2018-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17696
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756206
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756206 | Tuberculosis antigen cassettes | Oct 14, 2018 | Issued |
Array
(
[id] => 13867061
[patent_doc_number] => 20190029871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Method and System for Reducing the Likelihood of Colorectal Cancer in a Human Being
[patent_app_type] => utility
[patent_app_number] => 16/142171
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142171 | Method and system for reducing the likelihood of colorectal cancer in a human being | Sep 25, 2018 | Issued |
Array
(
[id] => 16236847
[patent_doc_number] => 20200254081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 16/647124
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647124
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647124 | COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE | Sep 13, 2018 | Abandoned |
Array
(
[id] => 14806323
[patent_doc_number] => 20190269771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PEPTIDE MIMOTOPE THAT INDUCES AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM TUBERCULOSIS LIPOARABINOMANNAN (LAM)
[patent_app_type] => utility
[patent_app_number] => 16/131655
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131655 | PEPTIDE MIMOTOPE THAT INDUCES AN IMMUNE RESPONSE AGAINST MYCOBACTERIUM TUBERCULOSIS LIPOARABINOMANNAN (LAM) | Sep 13, 2018 | Abandoned |
Array
(
[id] => 16282684
[patent_doc_number] => 20200276286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => SILICIFIED CELL REPLICAS, METHODS OF MAKING, AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 16/647245
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647245 | Silicified cell replicas, methods of making, and methods of using | Sep 12, 2018 | Issued |
Array
(
[id] => 16236794
[patent_doc_number] => 20200254028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => BACTERIAL EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 16/645019
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645019 | Bacterial extracellular vesicles | Sep 9, 2018 | Issued |
Array
(
[id] => 15420675
[patent_doc_number] => 10543240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Topical composition containing glycerin and yeast extract
[patent_app_type] => utility
[patent_app_number] => 16/117434
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6755
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16117434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/117434 | Topical composition containing glycerin and yeast extract | Aug 29, 2018 | Issued |
Array
(
[id] => 13867505
[patent_doc_number] => 20190030093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/117054
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16117054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/117054 | Composition for inducing proliferation or accumulation of regulatory T cells | Aug 29, 2018 | Issued |
Array
(
[id] => 18503604
[patent_doc_number] => 11701394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Compositions and methods for treating cholestatic disease
[patent_app_type] => utility
[patent_app_number] => 16/639492
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 143
[patent_figures_cnt] => 148
[patent_no_of_words] => 22396
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16639492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/639492 | Compositions and methods for treating cholestatic disease | Aug 13, 2018 | Issued |
Array
(
[id] => 14043487
[patent_doc_number] => 20190077850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => PATHOGEN BINDING METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/059799
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059799 | PATHOGEN BINDING METHODS AND COMPOSITIONS | Aug 8, 2018 | Abandoned |
Array
(
[id] => 17633879
[patent_doc_number] => 11344584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/651041
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 12977
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651041
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651041 | None | Aug 5, 2018 | Issued |
Array
(
[id] => 16466755
[patent_doc_number] => 20200368292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => TREATMENT OR PREVENTION OF GASTROINTESTINAL DYSBIOSIS
[patent_app_type] => utility
[patent_app_number] => 16/635428
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635428 | Treatment or prevention of gastrointestinal dysbiosis | Aug 1, 2018 | Issued |
Array
(
[id] => 13586517
[patent_doc_number] => 20180344807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/048397
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16048397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/048397 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Jul 29, 2018 | Abandoned |
Array
(
[id] => 16108625
[patent_doc_number] => 20200206335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => IMMUNOGENIC COMPOSITION COMPRISING A FUSION PEPTIDE DERIVED FROM SUPERANTIGEN TOXOIDS
[patent_app_type] => utility
[patent_app_number] => 16/633664
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633664
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633664 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Jul 24, 2018 | Issued |
Array
(
[id] => 16108513
[patent_doc_number] => 20200206279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/631776
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631776 | AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM | Jul 16, 2018 | Abandoned |
Array
(
[id] => 13774707
[patent_doc_number] => 20190000892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/031024
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/031024 | Compositions comprising bacterial strains | Jul 9, 2018 | Issued |
Array
(
[id] => 13867637
[patent_doc_number] => 20190030159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => COMPOSITIONS OF VACCINES AND ADJUVANTS AND METHODS FOR THE TREATMENT OF URINARY TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/031726
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/031726 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Jul 9, 2018 | Issued |
Array
(
[id] => 13867609
[patent_doc_number] => 20190030145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF USING THE SAME IN CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/025952
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025952 | RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF USING THE SAME IN CANCER IMMUNOTHERAPY | Jul 1, 2018 | Abandoned |
Array
(
[id] => 16932730
[patent_doc_number] => 20210198619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => INHIBITION OF COLONIC GROUP 3 INNATE LYMPHOID CELLS
[patent_app_type] => utility
[patent_app_number] => 16/625217
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625217
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625217 | INHIBITION OF COLONIC GROUP 3 INNATE LYMPHOID CELLS | Jun 21, 2018 | Abandoned |
Array
(
[id] => 16853497
[patent_doc_number] => 20210154242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => INACTIVATED BACILLUS COAGULANS AND USES THEREOF FOR INCREASING PHYSICAL PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 16/625661
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625661 | Inactivated | Jun 20, 2018 | Issued |